Merck & Company Inc (MRK)
Mexican Exchange · Mexico · prices in MXN · close of 23 Oct 2026
Key indicators
| Last close | MXN 2,708.00 |
|---|---|
| 52-week range | 1,531.00 – 2,846.00 |
| Return, 1 month / 3 months | +4.2% / +19.4% |
| Return, 1 year / 3 years | +74.2% / +58.0% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 31.1% |
| Worst drawdown (1 year) | -12.4% |
| Average daily value traded | 4.65M MXN |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Merck & Company is a pharmaceutical company based in the United States that discovers, develops and manufactures prescription medicines, vaccines and animal health products. Its human health business serves patients and healthcare providers through medicines for cancer, infectious disease, diabetes and other conditions, while its animal health arm supplies veterinary products to livestock and companion animal owners. The company also sells consumer health products in some markets.
Merck & Company Inc trades under the code MRK on the Mexican Exchange in Mexico, with its price quoted in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Merck & Company Inc (MRK) trades on the Mexican Exchange in Mexico. It last closed at MXN 2,708.00 on 23 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 9 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 74.2% and over the last three months it rose 19.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 24.4% | ||
| From 52-week high | -3.3% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 19.4% | ||
| 6-month return | 40.6% | ||
| 12-month return, skipping the last month | 67.2% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.4% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 4.65M MXN | ||
| Zero-volume days | 13.3% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | +4.2% |
| 3 months | +19.4% |
| 6 months | +40.6% |
| 1 year | +74.2% |
| 3 years | +58.0% |
| 5 years | +94.4% |
Signals
| 50-day / 200-day average | 2,561.68 / 2,177.22 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 52.51 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | MXN 14.5726 |
| 15 Jun 2026 | MXN 14.6212 |
| 13 Mar 2026 | MXN 15.2511 |
| 15 Dec 2025 | MXN 15.2800 |
| 15 Sep 2025 | MXN 14.8801 |
| 16 Jun 2025 | MXN 15.2924 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.